Development of a Pediatric Ventricular Assist Device
Development of a Pediatric Ventricular Assist Device
批准号:
7686022
负责人:
金额:
$132.21万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-03-30 至 2009-03-29
中文摘要
本提案的目的是开发一种儿科VAD (CCF PediPump),该VAD是基于磁性轴承支撑的旋转动态泵,可以为儿科遇到的所有患者尺寸提供支持。该泵的设计特点是没有密封,转子悬浮在磁性轴承上,从而具有极高的耐用性。该泵的第二个独特之处在于其尺寸极小,尺寸约为7 mm X 60 mm,在保持良好流量的同时,其物理位移不到MicroMed DeBakey或Jarvik 2000轴流泵的10%。事实上,该设备能够提供能够支持成人的压力和流量,远远超过支持2至25公斤体重范围内儿童的要求。在目前的形式中,将根据患者的大小使用两种包装概念:血管内配置将用于较大的儿童,而血管外配置将用于最小的儿童。由于其体积小,PediPump为即使是最小的婴儿提供了一个完全植入式系统的长期发展提供了真正的希望。此外,该装置适用于右心室支持(RVAD)、左心室支持(LVAD)和双心室支持(BVAD)。该装置具有高耐久性和卓越的生物相容性,对宿主的影响最小,包括潜在的最小抗凝或无抗凝,低水平的溶血和最小的感染风险。该系统所描述的单泵适用于短期支持,同时适用于动态慢性循环支持。
英文摘要
The purpose of this proposal is to develop a pediatric VAD (the CCF PediPump) that is based on a magnetic bearing supported, rotary dynamic pump that can provide support for the entire range of patient sizes encountered in pediatrics. The design of this pump features the absence of a seal with suspension of the rotor on magnetic bearings resulting in extremely high durability. A second, unique feature of this pump is its extremely small size measuring approximately 7 mm X 60 mm which imparts less than 10% of the physical displacement of the MicroMed DeBakey or Jarvik 2000 axial fiow pumps while retaining good flow capacity. In fact, the device is capable of providing pressure and flows capable of supporting adults, far exceeding requirements for support of children in the 2 to 25 kg weight range. In its present form, two packaging concepts wil be used based on patient size: an intravascuiar configuration will be used for older children while an extravascular configuration will be used for the smallest children. Because of its small size the PediPump provides the very real hope for long-term development of a totally implantable system for even the smallest infants. Further, this device is suitable for right ventricular support (RVAD), left ventricular support (LVAD) and biventricular support (BVAD). This device has high durability and superior biocompatibility with minimal host impact, including the potential for minimal or no anticoagulation, low levels of hemolysis and minimal infection risk. A single pump as described for this system is suitable for short-term support while being adaptable to ambulatory chronic circulatory support.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金